Bacterial Toxins for Cancer Therapy

Ontak-like human IL-2 fusion toxin

(2017) Zhaohui Wang et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells

(2017) N.-I. Zahaf  et al.   Scientific Reports

The assessment of HER2 status in breast cancer: the past, the present, and the future

(2016) Hiroaki Nitta et al.   PATHOLOGY INTERNATIONAL

Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results

(2015) Emily Mason-Osann et al.   Scientific Reports

Bacterial Type III Secretion Systems: Specialized Nanomachines for Protein Delivery into Target Cells

(2014) Jorge E. Galán et al.   Annual Review of Microbiology

LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins

(2014) B. Schorch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

(2013) Diana P. English et al.   Molecular Diagnosis & Therapy

Differential Effects of Denileukin Diftitox IL-2 Immunotoxin on NK and Regulatory T Cells in Nonhuman Primates

(2012) Y. Yamada et al.   JOURNAL OF IMMUNOLOGY

Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen

(2012) Andrew J. McCluskey et al.   Molecular Oncology

Changing the Receptor Specificity of Anthrax Toxin

(2012) A. Mechaly et al.   mBio

A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer

(2011) John E. Weldon et al.   FEBS Journal

A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice

(2011) Ichiro Inoshima et al.   NATURE MEDICINE

Mechanism of Diphtheria Toxin Catalytic Domain Delivery to the Eukaryotic Cell Cytosol and the Cellular Factors that Directly Participate in the Process

(2011) John R. Murphy   Toxins

Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake

(2010) L. Abrami et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

(2010) Tadeusz Robak   Mediterranean Journal of Hematology and Infectious Diseases

CAT-8015: A Second-Generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies

(2009) R. F. Alderson et al.   CLINICAL CANCER RESEARCH

Cell entry strategy of clostridial neurotoxins

(2009) Thomas Binz et al.   JOURNAL OF NEUROCHEMISTRY

Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T‐cell lymphoma and occult cirrhosis

(2008) Andrew B. Avarbock et al.   AMERICAN JOURNAL OF HEMATOLOGY